logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Howard M. Sandler

Cedars-Sinai Medical Center
H指数:104
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Assessing Quality and Adherence to PI-RADSv2.1 Minimum Technical Standards of Prostate MRI in NRG-GU005

评估前列腺MRI的质量和符合PI-RADSv2.1最低技术标准的情况：NRG-GU005研究

Journal of Magnetic Resonance Imaging
IF3.5
2025-10-080
OAAI
Stephanie Alley; Marion Tonneau; Damien Olivié; Clare M. Tempany-Afdhal; Peter L. Choyke; I. Baris Turkbey; Uulke A. van der Heide; Rodney J. Ellis; Samuel Kadoury; Thomas P. Boike; J. Daniel Pennington; Arthur Frazier; Colleen A. F. Lawton; Nelson Leong; Alina M. Mihai; Scott C. Morgan; Abhishek A. Solanki; Jeff M. Michalski; Felix Y. Feng; Howard M. Sandler; Cynthia Menard
Long term results of NRG Oncology RTOG 9601, a randomized trial of radiation with or without anti-androgens (AAT) in patients receiving salvage prostate bed radiation therapy post prostatectomy

NRG Oncology RTOG 9601试验的长期结果，该试验是一项随机试验，研究在前列腺切除术后接受挽救性前列腺床放射治疗的患者中，使用或不使用抗雄激素药物（AAT）的放射治疗效果。

international journal of radiation oncology biology physics
IF0
2025-08-050
PRE
Himanshu R. Lukka; Stephanie L. Pugh; William U. Shipley; Pierre P. Major; Oliver Sartor; Ian S. Dayes; Jean-Paul Bahary; Jason A. Efstathiou; Thomas M. Pisansky; Kenneth L. Zeitzer; Colleen A.F. Lawton; Robert T. Dess; Andrew S. Camarata; Alexander G. Balogh; Luis Souhami; Seth A. Rosenthal; J. Daniel Pennington; Wendy F. Seiferheld; Felix Y. Feng; Howard M. Sandler
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following Prostatectomy

前列腺癌患者在前列腺切除术后接受挽救性放射治疗的III期临床试验（NRG/RTOG 9601）中淋巴结检出数的预后影响

prostate
IF0
2025-07-210
PRE
Emily Chan; Stephanie L. Pugh; Jeffry P. Simko; Felix Feng; William U. Shipley; Himanshu R. Lukka; Jean-Paul Bahary; Thomas M. Pisansky; Kenneth Lee Zeitzer; Elizabeth Gore; Jason A. Efstathiou; Seth A. Rosenthal; Alexander G. Balogh; Richard D. Lovett; Anthony Wong; Robert T. Dess; L. Scott McGinnis; Michael Kuettel; Luda DeMora; Howard M. Sandler
Radiotherapy- Versus Surgery-based Treatment Strategy in High-risk Prostate Cancer

放疗与手术为基础的治疗策略在高风险前列腺癌中的比较

European Urology Oncology
IF9.3
2025-07-190
PRE
Soumyajit Roy; Yilun Sun; James A. Eastham; Martin Gleave; Christopher J.D. Wallis; Himisha A. Beltran; Amar U. Kishan; Angela Y. Jia; Nicholas G. Zaorsky; Himanshu Nagar; Jorge A. Garcia; Eric J. Small; Paul Nguyen; Gerhardt Attard; Rana R. McKay; Oliver Sartor; Alejandro Berlin; Seth A. Rosenthal; Susan Halabi; Randy Vince; Lee Ponsky; Scott C. Morgan; Raquibul Hannan; Adam Raben; Mack Roach; Jeff M. Michalski; Michael J. Morris; Howard M. Sandler; Daniel E. Spratt
Transcriptomic Analysis of Localized High-risk Prostate Cancer Improves Prognostication and Identifies Benefit from Adding Docetaxel to Definitive Radiotherapy with Androgen Suppression in the NRG Oncology/RTOG 0521 Phase 3 Trial

局部高危前列腺癌的转录组学分析改善了预后判断，并确定了在NRG肿瘤学/RTOG 0521 III期试验中，将多西他赛添加到根治性放疗联合雄激素抑制治疗中获益。

European Urology Oncology
IF9.3
2025-07-170
OAAI
Ryan M. Phillips; James A. Proudfoot; Elai Davicioni; Yang Liu; Daniel E. Spratt; Jeff M. Simko; Robert B. Den; Alan Pollack; Seth A. Rosenthal; A. Oliver Sartor; Christopher J. Sweeney; Gerhardt Attard; Leslie Longoria; Samir Patel; Michael W. Straza; Jason A. Efstathiou; Amit B. Shah; Karen E. Hoffman; Joseph P. Rodgers; Howard M. Sandler; Felix Y. Feng; Phuoc T. Tran
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data

非转移性前列腺癌术后放疗 (DADSPORT) 的雄激素抑制持续时间: 一项协作系统评价和汇总数据的荟萃分析

European Urology
IF25.2
2025-06-260
OAAI
Sarah Burdett; David J. Fisher; Jayne F. Tierney; Adrian D. Cook; Daniel E. Spratt; James J. Dignam; Wendy F. Seiferheld; Amar U. Kishan; Yilun Sun; Sylvie Chabaud; Jason A. Efstathiou; Christopher C. Parker; Alan Pollack; Paul Sargos; Igor Latorzeff; Meryem Brihoum; Charles N. Catton; Noel W. Clarke; Felix Y. Feng; Theodore G. Karrison; Pascal Pommier; Howard M. Sandler; Matthew R. Sydes; Claire L. Vale
Long-Term Results of Bladder Preservation With Twice-Daily Radiation Plus 5-Fluorouracil/ Cisplatin or Daily Radiation Plus Gemcitabine for Muscle-Invasive Bladder Cancer-Updated Report of NRG/RTOG 0712: A Randomized Phase 2 Trial
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2025-01-010
PRE
Coen, John J.; Rodgers, Joseph P.; Saylor, Philip J.; Lee, Cheryl T.; Wu, Chin-Lee; Parker, William; Lautenschlaeger, Tim; Zietman, Anthony L.; Efstathiou, Jason; Jani, Ashesh B.; Kucuk, Omer; Souhami, Luis; Pugh, Stephanie L.; Sandler, Howard M.; Shipley, William U.
Genomic classifier performance in intermediate-risk prostate cancer: results from NRG Oncology/RTOG 0126 randomized phase 3 trial (vol 117, pg 370, 2023)
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2024-12-010
PRE
Spratt, D. E.; Liu, V. Y. T.; Michalski, J.; Davicioni, E.; Berlin, A.; Simko, J. P.; Efstathiou, J. A.; Tran, P. T.; Sandler, H. M.; Hall, W. A.; Thompson, D. J. S.; Parliament, M. B.; Dayes, I. S.; Correa, R. J. M.; Robertson, J. M.; Gore, E. M.; Doncals, D. E.; Vigneault, E.; Souhami, L.; Karrison, T. G.; Feng, F. Y.
Biopsy-based Basal-luminal Subtyping Classifier in High-risk Prostate Cancer: A Combined Analysis of the NRG Oncology/RTOG 9202, 9413, and 9902 Phase 3 Trials

基于活检的基底-腔亚型分类器在高风险前列腺癌中的应用：NRG Oncology/RTOG 9202、9413和9902 III期临床试验的联合分析

European Urology Oncology
IF9.3
2024-11-130
PRE
Krishnan R. Patel; Paul L. Nguyen; James A. Proudfoot; Yang Liu; Alan Dal Pra; Daniel E. Spratt; Alan Pollack; Howard M. Sandler; Jason A. Efstathiou; Colleen Lawton; Jeffry P. Simko; Seth A. Rosenthal; Kenneth L. Zeitzer; Lucas C. Mendez; Alan C. Hartford; William A. Hall; Anand B. Desai; Stephanie L. Pugh; Elai Davicioni; Phuoc T. Tran
Meta-analysis of Individual Patient-level Data for a Multimodal Artificial Intelligence Biomarker in High-risk Prostate Cancer: Results from Six NRG/RTOG Phase 3 Randomized Trials

高风险前列腺癌中多模式人工智能生物标志物的个体患者水平数据的荟萃分析: 来自六项NRG/RTOG 3期随机试验的结果

EUROPEAN UROLOGY
IF25.2
2024-10-010
OA
Spratt, Daniel E.; Liu, Vinnie Y. T.; Jia, Angela Y.; Royce, Trevor J.; Sandler, Howard M.; Pugh, Stephanie L.; Tran, Phuoc T.; Feng, Felix Y.
External Validation of a Digital Pathology-based Multimodal Artificial Intelligence Architecture in the NRG/RTOG 9902 Phase 3 Trial

NRG/RTOG 9902 3期试验中基于数字病理学的多模态人工智能架构的外部验证

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-10-012
OA
Ross, Ashley E.; Zhang, Jingbin; Huang, Huei-Chung; Yamashita, Rikiya; Keim-Malpass, Jessica; Simko, Jeffry P.; Devries, Sandy; Morgan, Todd M.; Souhami, Luis; Dobelbower, Michael C.; Mcginnis, L. Scott; Jones, Christopher U.; Dess, Robert T.; Zeitzer, Kenneth L.; Choi, Kwang; Hartford, Alan C.; Michalski, Jeff M.; Raben, Adam; Gomella, Leonard G.; Sartor, A. Oliver; Rosenthal, Seth A.; Sandler, Howard M.; Spratt, Daniel E.; Pugh, Stephanie L.; Mohamad, Osama; Esteva, Andre; Chen, Emmalyn; Schaeffer, Edward M.; Tran, Phuoc T.; Feng, Felix Y.
Corrigendum to Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial[Eur. [Eur. Eurol. 84(2) (2023) 156-163]
EUROPEAN UROLOGY
IF25.2
2024-09-011
PRE
Sartor, Oliver; Karrison, Theodore G.; Sandler, Howard M.; Gomella, Leonard G.; Amin, Mahul; Purdy, James; Michalski, Jeff M.; Garzotto, Mark G.; Pervez, Nadeem; Balogh, Alexander G.; Rodrigues, George B.; Souhami, Luis; Reaume, M. Neil; Williams, Scott G.; Hannan, Raquibul; Jones, Christopher U.; Horwitz, Eric M.; Rodgers, Joseph P.; Feng, Felix Y.; Rosenthal, Seth A.
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202

局部晚期前列腺癌的心血管死亡率和雄激素剥夺的持续时间: NRG/RTOG 9202的长期更新

EUROPEAN UROLOGY FOCUS
IF5.6
2024-03-013
PRE
Mak, Kimberley S.; Bryan, Molly Scannell; Dignam, James J.; Shipley, William U.; Lin, Yue; Peters, Christopher A.; Gore, Elizabeth M.; Rosenthal, Seth A.; Zeitzer, Kenneth L.; D'Souza, David P.; Horwitz, Eric M.; Pisansky, Thomas M.; Maier, Jordan M.; Chafe, Susan M.; Robin, Tyler P.; Roach III, Mack; Tran, Phuoc T.; Souhami, Luis; Michalski, Jeff M.; Hartford, Alan C.; Feng, Felix Y.; Sandler, Howard M.; Efstathiou, Jason A.
Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Paclitaxel plus Trastuzumab with Daily Radiation or Paclitaxel Alone with Daily Irradiation
EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-02-010
PRE
Dahl, Douglas M.; Karrison, Theodore G.; Michaelson, M. Dror; Pham, Huong T.; Wu, Chin-Lee; Swanson, Gregory P.; Shipley, William U.; Vuky, Jacqueline; Lee, R. Jeffrey; Zietman, Anthony L.; Souhami, Luis; Chang, Brian K.; Deming, Richard L.; Ellerton, John A.; Sandler, Howard M.; Rodgers, Joseph P.; Feng, Felix Y.; Efstathiou, Jason A.

研究方向

暂未获取到该数据
J
Jeff M. Michalski
H 指数:86论文数:630被引数:2.7万
W
William U. Shipley
H 指数:93论文数:601被引数:3.4万
D
Daniel A. Hamstra
H 指数:46论文数:285被引数:8,347
M
Mack Roach
H 指数:83论文数:632被引数:3.0万
T
Thomas M. Pisansky
H 指数:63论文数:480被引数:2.1万
F
Felix Y. Feng
H 指数:109论文数:1,737被引数:5.0万
S
Seth A. Rosenthal
H 指数:66论文数:347被引数:1.7万
M
Martin G. Sanda
H 指数:72论文数:536被引数:2.6万
J
Jason A. Efstathiou
H 指数:67论文数:657被引数:2.1万
A
Anthony L. Zietman
H 指数:78论文数:782被引数:2.5万